Intelligence · Clinical pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
Pipeline programs
-
zelicapavir (therapeutic dose)
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial -
ziftomenib
Kura Oncology
Gastrointestinal Stromal Tumor (GIST)
1 trial -
zimberelimab
Arcus Biosciences
Advanced Solid Tumors
1 trial -
ziv-aflibercept
Regeneron UK Limited
Cancer
2 trials -
ziv-aflibercept
Regeneron UK Limited
Lymphoma
2 trials -
zlk20251119
Xiyuan Hospital of China Academy of Chinese Medical Sciences
DC-CIK Treatment
1 trial -
α-lactalbumin vaccine
Anixa Biosciences Inc
Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer
1 trial -
γδT Cell infusion agent
The First People's Hospital of Lianyungang
Leukemia, B-cell
1 trial -
MEN2501-01
Stemline Therapeutics B.V.
Platinum-Resistant ovarian cancer
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.